Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma

Fig. 5

Prognosis of patients according to the presence of DH HRCA and post-ASCT MRD status. (A, B) Probability of PFS (A) and OS (B) adjusted for the presence of DH HRCA and post-ASCT MRD status; (C) Cumulative incidence of progression or MRD resurgence for patients stratified by the number of HRCA after achieving post-ASCT MRD negativity. DH, double hit; MRD, minimal residual disease; HRCA, high-risk cytogenetics; PFS, progression free survival; OS, overall survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us